-+ 0.00%
-+ 0.00%
-+ 0.00%

Citigroup Maintains Buy on Veradermics, Raises Price Target to $160

Benzinga·07/16/2026 20:27:52
Listen to the news
Citigroup analyst Geoff Meacham maintains Veradermics (NYSE:MANE) with a Buy and raises the price target from $135 to $160.